1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GRACE THERAPEUTICS INC.
Grace Therapeutics Inc. XNAS: GRCE
Download real time
3.22 -0.04 (-1.23%)
35.08% Fall from 52W High
185.1K
XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Grace Therapeutics Inc. is on 12 Sep 2025 for the purpose of Grace Therapeutics Inc Annual General Meeting for 2025 See details


Insider Trading disclosures for Grace Therapeutics Inc.

The latest disclosure was made by S. George Kottayil in Grace Therapeutics Inc. where a trade of 10,000 Stock Option (Right to Buy) done was reported to US exchanges on May 9, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
S. George Kottayil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2025 10,000 10,000 - - Stock Option (Right to Buy)
Vimal Kavuru Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2025 10,000 10,000 - - Stock Option (Right to Buy)
Edward Neugeboren Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2025 10,000 10,000 - - Stock Option (Right to Buy)
A. Brian Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2025 10,000 10,000 - - Stock Option (Right to Buy)
Amresh Kumar VP Program Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2025 30,000 30,000 - - Stock Option (Right to Buy)
Carrie D'Andrea VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2025 30,000 30,000 - - Stock Option (Right to Buy)
Prashant Kohli Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2025 225,400 225,400 - - Stock Option (Right to Buy)
R. Loch Macdonald Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Apr 2025 40,000 40,000 - - Stock Option (Right to Buy)
Amresh Kumar VP Program Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2024 19,740 19,740 - - Stock Options (Right to Buy)
R. Loch Macdonald Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2024 25,380 25,380 - - Stock Options (Right to Buy)
Prashant Kohli Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2024 128,770 128,770 - - Stock Options (Right to Buy)
Carrie D'Andrea VP Program Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2024 19,740 19,740 - - Stock Options (Right to Buy)
Amresh Kumar VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2024 19,740 19,740 - - Stock Options (Right to Buy)
Carrie D'Andrea VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2024 19,740 19,740 - - Stock Options (Right to Buy)
George Kottayil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2023 22,500 22,500 - - Stock Options (Right to Buy)
Neugeboren Edward Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2023 22,500 22,500 - - Stock Options (Right to Buy)
Vimal Kavuru Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2023 10,000 10,000 - - Stock Options (Right to Buy)
Kohli Prashant Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2023 41,668 41,668 - - Stock Options (Right to Buy)
Davis A. Brian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2023 22,500 22,500 - - Stock Options (Right to Buy)
Amresh Kumar VP Program Management Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 42,000 42,000 - - Stock Options (Right to Buy)
Carrie D'Andrea VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 42,000 42,000 - - Stock Options (Right to Buy)
Prashant Kohli Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 208,334 208,334 - - Stock Options (Right to Buy)
Michael L. Derby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 12,500 12,500 - - Stock Options (Right to Buy)
Vimal Kavuru Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 12,500 12,500 - - Stock Options (Right to Buy)
R. Loch Macdonald Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 60,000 60,000 - - Stock Options (Right to Buy)
Donald Olds Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2023 12,500 12,500 - - Stock Options (Right to Buy)
Janelle D'Alvise Director, PRESIDENT & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 560,000 560,000 - - Stock Options (Right to Buy)
Brian D. Ford CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 165,000 165,000 - - Stock Options (Right to Buy)
Pierre Lemieux COO, Canada & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 165,000 165,000 - - Stock Options (Right to Buy)
George Kottayil COO, US Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 50,000 50,000 - - 06/22/2022
Jean Marie Canan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 42,100 42,100 - - Stock Options (Right to Buy)
Vimal Kavuru Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 42,100 42,100 - - Stock Options (Right to Buy)
Janelle D'Alvise Director, PRESIDENT & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 655,500 655,500 - - Stock Options (Right to Buy)
Roderick Carter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 42,100 42,100 - - Stock Options (Right to Buy)
Donald Olds Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 42,100 42,100 - - Stock Options (Right to Buy)
Pierre Lemieux COO, Canada & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 287,900 287,900 - - Stock Options (Right to Buy)
Brian D. Ford CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 287,900 287,900 - - Stock Options (Right to Buy)
William A. Haseltine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 42,100 42,100 - - Stock Options (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters